ALKS 2680

· Alkermes, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ALKS 2680, covering 2025-10-14 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304) [Phase 3]

See pricing